Touyun Biotech Group (HKSE:01332) Accounts Receivable : HK$31.9 Mil (As of Jun. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Touyun Biotech Group Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Touyun Biotech Group's accounts receivables for the quarter that ended in Jun. 2024 was HK$31.9 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Touyun Biotech Group's Days Sales Outstanding for the quarter that ended in Jun. 2024 was 78.27.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Touyun Biotech Group's Net-Net Working Capital per share for the quarter that ended in Jun. 2024 was HK$-0.20.

Touyun Biotech Group Accounts Receivable Historical Data

The historical data trend for Touyun Biotech Group's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Touyun Biotech Group Accounts Receivable Chart

Touyun Biotech Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Receivable

Get a 7-Day Free Trial

54.76

58.69

66.29

41.45

27.14

Touyun Biotech Group Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Accounts Receivable	Get a 7-Day Free Trial															86.11	41.45	31.27	27.14	31.85

Touyun Biotech Group Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Touyun Biotech Group Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Touyun Biotech Group's Days Sales Outstanding for the quarter that ended in Jun. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	31.85	/	74.267	*	91
=	78.27

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Touyun Biotech Group's accounts receivable are only considered to be worth 75% of book value:

Touyun Biotech Group's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2024 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(13.757	+	0.75 * 31.85	+	0.5 * 15.294	-	597.417
-	0	-	21.071)	/	2805.95
=	-0.20

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

Touyun Biotech Group Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Touyun Biotech Group's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Touyun Biotech Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Packaging & Containers » Touyun Biotech Group Ltd (HKSE:01332) » Definitions » Accounts Receivable

Comparable Companies

Traded in Other Exchanges

N/A

Address

6 Tonnochy Road, 12th Floor, Kwan Chart Tower, Wanchai, Hong Kong, HKG

Website

https://www.touyunbiotech.com.hk

Touyun Biotech Group Ltd, formerly China Touyun Tech Group Ltd, an investment holding company, designs, develops, manufactures, and sells packaging products and point-of-sales display units. It operates with four business segments, Packaging Products, Treasury Investment, QR code business, and Chlamydomonas reinhardtii product business. Through the Packaging Products segment, it offers watch boxes, jewelry boxes, eyewear cases, bags and pouches, and display units whereas the Treasury segment engages in the trading of securities and money lending activities. It derives a majority of its revenue from the Packaging products. The business activity of the group is operated in Hong Kong, Mainland China, North and South America, and other countries.

Executives

Wang Liang	2101 Beneficial owner
Tian Yuze	2101 Beneficial owner
Tian Yuze	2101 Beneficial owner
Qiao Yanfeng	2201 Interest of corporation controlled by you
Qin Fen	2101 Beneficial owner

Touyun Biotech Group Headlines

No Headlines